[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @adamfeuerstein Adam Feuerstein ✡️ Adam Feuerstein ✡️ posts on X about $aclx, $srpt, vivo, $wve the most. They currently have XXXXXXX followers and XX posts still getting attention that total XXXXXX engagements in the last XX hours. ### Engagements: XXXXXX [#](/creator/twitter::102094857/interactions)  - X Week XXXXXXX -XX% - X Month XXXXXXXXX -XX% - X Months XXXXXXXXX +28% - X Year XXXXXXXXXX +44% ### Mentions: XX [#](/creator/twitter::102094857/posts_active)  - X Week XX -XX% - X Month XXX -XX% - X Months XXX +48% - X Year XXXXX +63% ### Followers: XXXXXXX [#](/creator/twitter::102094857/followers)  - X Week XXXXXXX +0.10% - X Month XXXXXXX +0.02% - X Months XXXXXXX +3.30% - X Year XXXXXXX +5.30% ### CreatorRank: XXXXXXX [#](/creator/twitter::102094857/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) XXXXX% [technology brands](/list/technology-brands) XXXX% **Social topic influence** [$aclx](/topic/$aclx) #5, [$srpt](/topic/$srpt) #31, [vivo](/topic/vivo) 4.41%, [$wve](/topic/$wve) #8, [$dyn](/topic/$dyn) #3, [$kymr](/topic/$kymr) #11, [novartis](/topic/novartis) #17, [fda](/topic/fda) 2.94%, [$jnj](/topic/$jnj) #61, [$qure](/topic/$qure) #43 **Top accounts mentioned or mentioned by** [@kinatsofrim](/creator/undefined) [@jasonmmast](/creator/undefined) [@seedy19tron](/creator/undefined) [@statnews](/creator/undefined) [@biotechch](/creator/undefined) [@fwcweather](/creator/undefined) [@biotechanalysst](/creator/undefined) [@matthewherper](/creator/undefined) [@mbrushstocks](/creator/undefined) [@bullishbruk](/creator/undefined) [@justiceforb_md](/creator/undefined) [@snackbiotech](/creator/undefined) [@lizzylaw](/creator/undefined) [@jonathanwosen](/creator/undefined) [@sanctuarybio](/creator/undefined) [@pemulisking](/creator/undefined) [@msollender](/creator/undefined) [@sportsbios](/creator/undefined) [@elikorey](/creator/undefined) [@biotechbull2](/creator/undefined) **Top assets mentioned** [Arcellx, Inc. Common Stock (ACLX)](/topic/$aclx) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Wave Life Sciences Ltd. Ordinary Shares (WVE)](/topic/$wve) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn) [Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr) [Novartis AG (NVS)](/topic/novartis) [Johnson & Johnson (JNJ)](/topic/$jnj) [uniQure N.V. (QURE)](/topic/$qure) [Terns Pharmaceuticals, Inc. Common Stock (TERN)](/topic/$tern) [Vera Therapeutics, Inc. Class A Common Stock (VERA)](/topic/$vera) [Crinetics Pharmaceuticals, Inc. (CRNX)](/topic/$crnx) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [ImmunityBio, Inc. Common Stock (IBRX)](/topic/$ibrx) [Soleno Therapeutics, Inc. Common Stock (SLNO)](/topic/$slno) [Novo-Nordisk (NVO)](/topic/$nvo) [Sanofi (SNY)](/topic/sanofi) [Synthetify (SNY)](/topic/$sny) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Eli Lilly and Company (LLY)](/topic/eli-lilly) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) ### Top Social Posts Top posts by engagements in the last XX hours "$ACLX sold off on the Kelonia Therapeutics (private) #ASH25 LBA1 in vivo BCMA CAR-T for multiple myeloma" [X Link](https://x.com/adamfeuerstein/status/1993014262122590549) 2025-11-24T17:50Z 122K followers, 30.3K engagements "BREAKING: Top drug regulator Richard Pazdur set to leave FDA via @LizzyLaw_" [X Link](https://x.com/adamfeuerstein/status/1995887321653403660) 2025-12-02T16:06Z 122K followers, 123.8K engagements "$2 billion of stock being offered tonight collectively from $GPCR $DYN $VERA $FULC $WVE $KYMR and it's only 4:06 pm" [X Link](https://x.com/adamfeuerstein/status/1998137228342743433) 2025-12-08T21:06Z 122K followers, 22.4K engagements "Richard Ebright - the pathetic anger-addled charlatan will spend the remainder of his useless life screaming obscenities into the dark void of X. Enjoy your irrelevance Dick" [X Link](https://x.com/adamfeuerstein/status/1998412057671033141) 2025-12-09T15:18Z 122K followers, 28K engagements "Crinetics $CRNX wins FDA approval for acromegaly drug faces competition with Novartis and Ipsen via @JonathanWosen" [X Link](https://x.com/adamfeuerstein/status/1971324752183874035) 2025-09-25T21:23Z 122K followers, 22.4K engagements "$SRPT New Elevidys label" [X Link](https://x.com/adamfeuerstein/status/1989408177537057011) 2025-11-14T19:00Z 122K followers, 15.8K engagements "FDAs stronger warning on Sarepta $SRPT gene therapy raises new questions about heart risk via @Jasonmmast and me" [X Link](https://x.com/adamfeuerstein/status/1990804877921149334) 2025-11-18T15:30Z 122K followers, 20K engagements "@Sanctuary_Bio $ACLX was going to sell off on ASH anyway so maybe it's just happening sooner" [X Link](https://x.com/adamfeuerstein/status/1993017978393334264) 2025-11-24T18:04Z 122K followers, 2530 engagements "Here is a clip from the Kelonia #ASH XX abstract. FYI. $ACLX Results: Patients (N=3) ranged from age 61-72 and their time from diagnosis was 7.9-9.4 yrs. All had high-risk cytogenetics and 3-4 prior lines of therapy. Two were refractory to a PI an IMiD and anti-CD38 therapy. All were nave to BCMA-targeted therapies; none had extramedullary involvement. Time from consent to infusion was 13-18 days. All patients experienced treatment-emergent adverse events (AEs) primarily around infusion and during CAR-T expansion. Two patients developed infusion-related reaction (IRR) 30-60 min post-infusion" [X Link](https://x.com/adamfeuerstein/status/1993019409510580532) 2025-11-24T18:10Z 122K followers, 17.6K engagements "@bigpharmaguy Not insane. You're correct. The competitive hit to $ACLX y'day was present (that $JNJ abstract) and future (the in vivo CAR-T) I didn't see the former until later" [X Link](https://x.com/adamfeuerstein/status/1993270575465198043) 2025-11-25T10:48Z 122K followers, 1163 engagements "$QURE FDA update: In the final meeting minutes and consistent with uniQures November X 2025 press release the FDA conveyed that data submitted from the Phase I/II studies of AMT-130 are currently unlikely to provide the primary evidence to support a BLA submission. uniQure is carefully evaluating the feedback and plans to urgently request a follow-up meeting with the FDA to take place in the first quarter of 2026" [X Link](https://x.com/adamfeuerstein/status/1996552896184229977) 2025-12-04T12:11Z 122K followers, 32.8K engagements "New data from Gilead Arcellx multiple myeloma CAR-T suggest benefit over rival treatment $GILD $ACLX $JNJ $LEGN #ASH25" [X Link](https://x.com/adamfeuerstein/status/1997697852726997116) 2025-12-07T16:00Z 122K followers, 15.9K engagements "$WVE We've entered the "patients are heavier is good" phase of the obesity hype cycle" [X Link](https://x.com/adamfeuerstein/status/1998012392576286803) 2025-12-08T12:50Z 122K followers, 41.2K engagements "$BMY should buy $TERN $BMY needs to buy $TERN If everyone else can make M&A predictions on this site so can I" [X Link](https://x.com/adamfeuerstein/status/1998121768393855196) 2025-12-08T20:05Z 122K followers, 20.8K engagements "Friends - My humble request is that you sign up for the email version of my weekly newsletter. Its contents are also posted on STAT's website but the email arrives every Thursday at 6:30 am ET which means you can hate-read it over coffee" [X Link](https://x.com/adamfeuerstein/status/1849459489881174353) 2024-10-24T14:34Z 122K followers, 311.5K engagements "Sareptas $SRPT dismal quarter marred by drug failures and a long list of excuses" [X Link](https://x.com/adamfeuerstein/status/1985691093707702654) 2025-11-04T12:50Z 122K followers, 10.6K engagements "This week's Biotech Scorecard newsletter: The FDA is a mess but don't blame it for everything I write about $QURE and $BHVN Re: Uniqure and its gene therapy for Huntington's disease the dissonance between the FDA's words and actions can be confusing. Approving AMT-130 seems like a no-brainer win for the FDA and the policy initiatives pushed by its leadership. The reversal certainly has Prasad's conservative data-stickler fingerprints all over it BUT. You have to consider the possibility that there is a significant issue with the AMT-130 data the composition of the external control group or" [X Link](https://x.com/adamfeuerstein/status/1986440412781748724) 2025-11-06T14:27Z 122K followers, 29.1K engagements "$IBRX is more than welcome to submit data to the FDA to seek an expanded approval for Anktiva / Bioshield beyond its limited approval for bladder cancer. Earlier this year the company said it was going to file for a lung cancer approval then reneged and is now conducting another clinical trial. Its effort to expand the existing approval in bladder cancer was rejected by the FDA witout a review. Making unsubstantiated claims on X isn't a substitute for clinical data" [X Link](https://x.com/adamfeuerstein/status/1987289289718452355) 2025-11-08T22:41Z 122K followers, 5999 engagements "$SLNO is repurchasing $100M of its stock. Strong move" [X Link](https://x.com/adamfeuerstein/status/1988216394375430456) 2025-11-11T12:05Z 122K followers, 33.5K engagements "This week's Biotech Scorecard newsletter: Richard Pazdur surely has many items on his to-do list now that hes the top drug regulator at the Food and Drug Administration. One of the decisions he will soon help make how to deal with the dangling accelerated approvals given to Sarepta Therapeutics $SRPT for its Duchenne muscular dystrophy drugs will tell us a lot about how much independence and scientific rigor Pazdur intends to bring to the new job" [X Link](https://x.com/adamfeuerstein/status/1991522875677827521) 2025-11-20T15:03Z 122K followers, 12.1K engagements "Also my gratitude list for 2025" [X Link](https://x.com/adamfeuerstein/status/1991522877129257309) 2025-11-20T15:03Z 122K followers, 5869 engagements "Last night at the CTAD meeting $NVO presented the EVOKE studies of oral semaglutide in Alzheimer's disease. It's hard to tell but yes there are two lines on each of those graphs" [X Link](https://x.com/adamfeuerstein/status/1996546528178319693) 2025-12-04T11:46Z 122K followers, 23.4K engagements "$DYN Dyne Therapeutics plans to file for approval for next-generation Duchenne drug. The medicine could be a more effective version of controversial Sarepta $SRPT drug via @Jasonmmast" [X Link](https://x.com/adamfeuerstein/status/1997994045642014826) 2025-12-08T11:37Z 122K followers, 10.5K engagements "Kymera $KYMR drug positioned to rival Sanofi and Regenerons Dupixent succeeds in early-stage eczema trial via @JonathanWosen $SNY $REGN" [X Link](https://x.com/adamfeuerstein/status/1998000053370118270) 2025-12-08T12:01Z 122K followers, 13.1K engagements "$TERN Results in Terns leukemia drug study suggest it could be a successor to Novartis $NVS blockbuster #ASH25" [X Link](https://x.com/adamfeuerstein/status/1998116880872059291) 2025-12-08T19:46Z 122K followers, 15.2K engagements "$ABVX raised $700M in July and didnt use JP Morgan. If youre searching for a likely reason ABVX Is not presenting at JPM26 see above" [X Link](https://x.com/adamfeuerstein/status/1998553547361927482) 2025-12-10T00:41Z 122K followers, 84K engagements "In this week's Biotech Scorecard newsletter: $WVE Waves gym bro obesity drug is story over substance" [X Link](https://x.com/adamfeuerstein/status/1999099768279085317) 2025-12-11T12:51Z 122K followers, 39.7K engagements "Hey folks - Reminder that we'll be gathering on Tuesday at X pm ET to remember and celebrate @MSollender and @Sports_bios. Look out for the @BiotechCH link and thanks to them for graciously hosting the event. If you want to say a few words on Tuesday reach out to me on DM. I'll gather a list" [X Link](https://x.com/adamfeuerstein/status/1999523072592748838) 2025-12-12T16:53Z 122K followers, 14.8K engagements "$ABVX reported third-quarter results but nowhere in its press release does it mention Eli Lilly jets or being acquired. Huh. so weird" [X Link](https://x.com/adamfeuerstein/status/2000675701653959155) 2025-12-15T21:13Z 122K followers, 42.3K engagements "In a banner year for biopharma here are the best industry CEOs of 2025 My 😇 list: The Metsera duo make it of course as does our trillion-dollar guy. Abavaxians will be happy to know that despite my occasional shit-posting I do recognize the tremendous job your man did this year. He makes the list. I also fulfilled my promise (well deserved) to a certain former "zombie" CEO who did the right thing. Read more below" [X Link](https://x.com/adamfeuerstein/status/2000928337070318062) 2025-12-16T13:57Z 122K followers, 20.6K engagements "STAT @ #JPM26 housekeeping note: Register for our live event on Mon. evening Jan. XX. On stage: Me in conversation w/ Rod Wong of RTW Investments and Agustin Mohedas from Janus Henderson. Two whipsmart biotech investors not to be missed. $ALNY CEO Yvonne Greenstreet fireside chatting with @matthewherper More details and register here:" [X Link](https://x.com/adamfeuerstein/status/2001016542742327393) 2025-12-16T19:48Z 122K followers, 8086 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@adamfeuerstein Adam Feuerstein ✡️
Adam Feuerstein ✡️ posts on X about $aclx, $srpt, vivo, $wve the most. They currently have XXXXXXX followers and XX posts still getting attention that total XXXXXX engagements in the last XX hours.
Engagements: XXXXXX #
- X Week XXXXXXX -XX%
- X Month XXXXXXXXX -XX%
- X Months XXXXXXXXX +28%
- X Year XXXXXXXXXX +44%
Mentions: XX #
- X Week XX -XX%
- X Month XXX -XX%
- X Months XXX +48%
- X Year XXXXX +63%
Followers: XXXXXXX #
- X Week XXXXXXX +0.10%
- X Month XXXXXXX +0.02%
- X Months XXXXXXX +3.30%
- X Year XXXXXXX +5.30%
CreatorRank: XXXXXXX #
Social Influence
Social category influence stocks XXXXX% technology brands XXXX%
Social topic influence $aclx #5, $srpt #31, vivo 4.41%, $wve #8, $dyn #3, $kymr #11, novartis #17, fda 2.94%, $jnj #61, $qure #43
Top accounts mentioned or mentioned by @kinatsofrim @jasonmmast @seedy19tron @statnews @biotechch @fwcweather @biotechanalysst @matthewherper @mbrushstocks @bullishbruk @justiceforb_md @snackbiotech @lizzylaw @jonathanwosen @sanctuarybio @pemulisking @msollender @sportsbios @elikorey @biotechbull2
Top assets mentioned Arcellx, Inc. Common Stock (ACLX) Sarepta Therapeutics, Inc. (SRPT) Wave Life Sciences Ltd. Ordinary Shares (WVE) Dyne Therapeutics, Inc. Common Stock (DYN) Kymera Therapeutics, Inc. Common Stock (KYMR) Novartis AG (NVS) Johnson & Johnson (JNJ) uniQure N.V. (QURE) Terns Pharmaceuticals, Inc. Common Stock (TERN) Vera Therapeutics, Inc. Class A Common Stock (VERA) Crinetics Pharmaceuticals, Inc. (CRNX) Gilead Sciences, Inc. (GILD) Bristol-Myers Squibb Co (BMY) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) ImmunityBio, Inc. Common Stock (IBRX) Soleno Therapeutics, Inc. Common Stock (SLNO) Novo-Nordisk (NVO) Sanofi (SNY) Synthetify (SNY) Regeneron Pharmaceuticals Inc (REGN) Eli Lilly and Company (LLY) Alnylam Pharmaceuticals, Inc. (ALNY)
Top Social Posts
Top posts by engagements in the last XX hours
"$ACLX sold off on the Kelonia Therapeutics (private) #ASH25 LBA1 in vivo BCMA CAR-T for multiple myeloma"
X Link 2025-11-24T17:50Z 122K followers, 30.3K engagements
"BREAKING: Top drug regulator Richard Pazdur set to leave FDA via @LizzyLaw_"
X Link 2025-12-02T16:06Z 122K followers, 123.8K engagements
"$2 billion of stock being offered tonight collectively from $GPCR $DYN $VERA $FULC $WVE $KYMR and it's only 4:06 pm"
X Link 2025-12-08T21:06Z 122K followers, 22.4K engagements
"Richard Ebright - the pathetic anger-addled charlatan will spend the remainder of his useless life screaming obscenities into the dark void of X. Enjoy your irrelevance Dick"
X Link 2025-12-09T15:18Z 122K followers, 28K engagements
"Crinetics $CRNX wins FDA approval for acromegaly drug faces competition with Novartis and Ipsen via @JonathanWosen"
X Link 2025-09-25T21:23Z 122K followers, 22.4K engagements
"$SRPT New Elevidys label"
X Link 2025-11-14T19:00Z 122K followers, 15.8K engagements
"FDAs stronger warning on Sarepta $SRPT gene therapy raises new questions about heart risk via @Jasonmmast and me"
X Link 2025-11-18T15:30Z 122K followers, 20K engagements
"@Sanctuary_Bio $ACLX was going to sell off on ASH anyway so maybe it's just happening sooner"
X Link 2025-11-24T18:04Z 122K followers, 2530 engagements
"Here is a clip from the Kelonia #ASH XX abstract. FYI. $ACLX Results: Patients (N=3) ranged from age 61-72 and their time from diagnosis was 7.9-9.4 yrs. All had high-risk cytogenetics and 3-4 prior lines of therapy. Two were refractory to a PI an IMiD and anti-CD38 therapy. All were nave to BCMA-targeted therapies; none had extramedullary involvement. Time from consent to infusion was 13-18 days. All patients experienced treatment-emergent adverse events (AEs) primarily around infusion and during CAR-T expansion. Two patients developed infusion-related reaction (IRR) 30-60 min post-infusion"
X Link 2025-11-24T18:10Z 122K followers, 17.6K engagements
"@bigpharmaguy Not insane. You're correct. The competitive hit to $ACLX y'day was present (that $JNJ abstract) and future (the in vivo CAR-T) I didn't see the former until later"
X Link 2025-11-25T10:48Z 122K followers, 1163 engagements
"$QURE FDA update: In the final meeting minutes and consistent with uniQures November X 2025 press release the FDA conveyed that data submitted from the Phase I/II studies of AMT-130 are currently unlikely to provide the primary evidence to support a BLA submission. uniQure is carefully evaluating the feedback and plans to urgently request a follow-up meeting with the FDA to take place in the first quarter of 2026"
X Link 2025-12-04T12:11Z 122K followers, 32.8K engagements
"New data from Gilead Arcellx multiple myeloma CAR-T suggest benefit over rival treatment $GILD $ACLX $JNJ $LEGN #ASH25"
X Link 2025-12-07T16:00Z 122K followers, 15.9K engagements
"$WVE We've entered the "patients are heavier is good" phase of the obesity hype cycle"
X Link 2025-12-08T12:50Z 122K followers, 41.2K engagements
"$BMY should buy $TERN $BMY needs to buy $TERN If everyone else can make M&A predictions on this site so can I"
X Link 2025-12-08T20:05Z 122K followers, 20.8K engagements
"Friends - My humble request is that you sign up for the email version of my weekly newsletter. Its contents are also posted on STAT's website but the email arrives every Thursday at 6:30 am ET which means you can hate-read it over coffee"
X Link 2024-10-24T14:34Z 122K followers, 311.5K engagements
"Sareptas $SRPT dismal quarter marred by drug failures and a long list of excuses"
X Link 2025-11-04T12:50Z 122K followers, 10.6K engagements
"This week's Biotech Scorecard newsletter: The FDA is a mess but don't blame it for everything I write about $QURE and $BHVN Re: Uniqure and its gene therapy for Huntington's disease the dissonance between the FDA's words and actions can be confusing. Approving AMT-130 seems like a no-brainer win for the FDA and the policy initiatives pushed by its leadership. The reversal certainly has Prasad's conservative data-stickler fingerprints all over it BUT. You have to consider the possibility that there is a significant issue with the AMT-130 data the composition of the external control group or"
X Link 2025-11-06T14:27Z 122K followers, 29.1K engagements
"$IBRX is more than welcome to submit data to the FDA to seek an expanded approval for Anktiva / Bioshield beyond its limited approval for bladder cancer. Earlier this year the company said it was going to file for a lung cancer approval then reneged and is now conducting another clinical trial. Its effort to expand the existing approval in bladder cancer was rejected by the FDA witout a review. Making unsubstantiated claims on X isn't a substitute for clinical data"
X Link 2025-11-08T22:41Z 122K followers, 5999 engagements
"$SLNO is repurchasing $100M of its stock. Strong move"
X Link 2025-11-11T12:05Z 122K followers, 33.5K engagements
"This week's Biotech Scorecard newsletter: Richard Pazdur surely has many items on his to-do list now that hes the top drug regulator at the Food and Drug Administration. One of the decisions he will soon help make how to deal with the dangling accelerated approvals given to Sarepta Therapeutics $SRPT for its Duchenne muscular dystrophy drugs will tell us a lot about how much independence and scientific rigor Pazdur intends to bring to the new job"
X Link 2025-11-20T15:03Z 122K followers, 12.1K engagements
"Also my gratitude list for 2025"
X Link 2025-11-20T15:03Z 122K followers, 5869 engagements
"Last night at the CTAD meeting $NVO presented the EVOKE studies of oral semaglutide in Alzheimer's disease. It's hard to tell but yes there are two lines on each of those graphs"
X Link 2025-12-04T11:46Z 122K followers, 23.4K engagements
"$DYN Dyne Therapeutics plans to file for approval for next-generation Duchenne drug. The medicine could be a more effective version of controversial Sarepta $SRPT drug via @Jasonmmast"
X Link 2025-12-08T11:37Z 122K followers, 10.5K engagements
"Kymera $KYMR drug positioned to rival Sanofi and Regenerons Dupixent succeeds in early-stage eczema trial via @JonathanWosen $SNY $REGN"
X Link 2025-12-08T12:01Z 122K followers, 13.1K engagements
"$TERN Results in Terns leukemia drug study suggest it could be a successor to Novartis $NVS blockbuster #ASH25"
X Link 2025-12-08T19:46Z 122K followers, 15.2K engagements
"$ABVX raised $700M in July and didnt use JP Morgan. If youre searching for a likely reason ABVX Is not presenting at JPM26 see above"
X Link 2025-12-10T00:41Z 122K followers, 84K engagements
"In this week's Biotech Scorecard newsletter: $WVE Waves gym bro obesity drug is story over substance"
X Link 2025-12-11T12:51Z 122K followers, 39.7K engagements
"Hey folks - Reminder that we'll be gathering on Tuesday at X pm ET to remember and celebrate @MSollender and @Sports_bios. Look out for the @BiotechCH link and thanks to them for graciously hosting the event. If you want to say a few words on Tuesday reach out to me on DM. I'll gather a list"
X Link 2025-12-12T16:53Z 122K followers, 14.8K engagements
"$ABVX reported third-quarter results but nowhere in its press release does it mention Eli Lilly jets or being acquired. Huh. so weird"
X Link 2025-12-15T21:13Z 122K followers, 42.3K engagements
"In a banner year for biopharma here are the best industry CEOs of 2025 My 😇 list: The Metsera duo make it of course as does our trillion-dollar guy. Abavaxians will be happy to know that despite my occasional shit-posting I do recognize the tremendous job your man did this year. He makes the list. I also fulfilled my promise (well deserved) to a certain former "zombie" CEO who did the right thing. Read more below"
X Link 2025-12-16T13:57Z 122K followers, 20.6K engagements
"STAT @ #JPM26 housekeeping note: Register for our live event on Mon. evening Jan. XX. On stage: Me in conversation w/ Rod Wong of RTW Investments and Agustin Mohedas from Janus Henderson. Two whipsmart biotech investors not to be missed. $ALNY CEO Yvonne Greenstreet fireside chatting with @matthewherper More details and register here:"
X Link 2025-12-16T19:48Z 122K followers, 8086 engagements